| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinoma
|
Reni, M.
|
|
2007
|
62 |
4 |
p. 673-678
|
artikel
|
| 2 |
Anti-microtubule activity of tubeimoside I and its colchicine binding site of tubulin
|
Ma, Rundi
|
|
2007
|
62 |
4 |
p. 559-568
|
artikel
|
| 3 |
Antitumour effect of combination treatment with Sabarubicin (MEN 10755) and cis-platin (DDP) in human lung tumour xenograft
|
Bigioni, M.
|
|
2007
|
62 |
4 |
p. 621-629
|
artikel
|
| 4 |
A phase I safety, pharmacological, and biological study of the farnesyl protein transferase inhibitor, lonafarnib (SCH 663366), in combination with cisplatin and gemcitabine in patients with advanced solid tumors
|
Chow, Laura Q. M.
|
|
2007
|
62 |
4 |
p. 631-646
|
artikel
|
| 5 |
A phase I trial of gemcitabine in combination with patupilone in patients with advanced solid tumors
|
Schelman, William
|
|
2007
|
62 |
4 |
p. 727-733
|
artikel
|
| 6 |
Biological properties of 4-methyl-2,7-diamino-5,10-diphenyl-4,9-diazapyrenium hydrogensulfate (ADAP)
|
Marczi, Saška
|
|
2007
|
62 |
4 |
p. 595-604
|
artikel
|
| 7 |
BRCA1 modulates sensitivity to 5F-203 by regulating xenobiotic stress-inducible protein levels and EROD activity
|
Kang, Hyo Jin
|
|
2007
|
62 |
4 |
p. 689-697
|
artikel
|
| 8 |
Cisplatin, gemcitabine and treosulfan is effective in chemotherapy-pretreated relapsed stage IV uveal melanoma patients
|
Atzpodien, Jens
|
|
2007
|
62 |
4 |
p. 685-688
|
artikel
|
| 9 |
c-Jun-NH2-terminal kinase potentiates apoptotic cell death in response to carboplatin in B lymphoma cells
|
Takada, Eiko
|
|
2007
|
62 |
4 |
p. 569-576
|
artikel
|
| 10 |
Delineation of the interactions between the chemotherapeutic agent eribulin mesylate (E7389) and human CYP3A4
|
Zhang, Z.-Y.
|
|
2008
|
62 |
4 |
p. 707-716
|
artikel
|
| 11 |
Effect of pure curcumin, demethoxycurcumin, and bisdemethoxycurcumin on WT1 gene expression in leukemic cell lines
|
Anuchapreeda, Songyot
|
|
2007
|
62 |
4 |
p. 585-594
|
artikel
|
| 12 |
Factors affecting sensitivity to antitumor platinum derivatives of human colorectal tumor cell lines
|
Kitada, Noriaki
|
|
2007
|
62 |
4 |
p. 577-584
|
artikel
|
| 13 |
Imatinib inhibition of fludarabine uptake in T-lymphocytes
|
Woodahl, Erica L.
|
|
2007
|
62 |
4 |
p. 735-739
|
artikel
|
| 14 |
Impact of celecoxib on capecitabine tolerability and activity in pretreated metastatic breast cancer: results of a phase II study with biomarker evaluation
|
Fabi, Alessandra
|
|
2007
|
62 |
4 |
p. 717-725
|
artikel
|
| 15 |
Inhibition by erlotinib of primary lung adenocarcinoma at an early stage in male mice
|
Zerbe, Laura K.
|
|
2007
|
62 |
4 |
p. 605-620
|
artikel
|
| 16 |
Intraperitoneal gemcitabine pharmacokinetics: a pilot and pharmacokinetic study in patients with advanced adenocarcinoma of the pancreas
|
Gamblin, T. Clark
|
|
2007
|
62 |
4 |
p. 647-653
|
artikel
|
| 17 |
Molecular predictors of human nervous system cancer responsiveness to enediyne chemotherapy
|
Rogers, Danny
|
|
2008
|
62 |
4 |
p. 699-706
|
artikel
|
| 18 |
Pharmacokinetics of heated intraperitoneal oxaliplatin
|
Ferron, G.
|
|
2007
|
62 |
4 |
p. 679-683
|
artikel
|
| 19 |
Pharmacokinetics of oral fenretinide in neuroblastoma patients: indications for optimal dose and dosing schedule also with respect to the active metabolite 4-oxo-fenretinide
|
Formelli, Franca
|
|
2007
|
62 |
4 |
p. 655-665
|
artikel
|
| 20 |
Prompt and sustained response of a steroid-refractory autoimmune hemolytic anemia to a rituximab-based therapy in a chronic lymphocytic leukemia patient
|
Gentile, Massimo
|
|
2007
|
62 |
4 |
p. 741-743
|
artikel
|
| 21 |
Tailored preoperative treatment of locally advanced triple negative (hormone receptor negative and HER2 negative) breast cancer with epirubicin, cisplatin, and infusional fluorouracil followed by weekly paclitaxel
|
Torrisi, Rosalba
|
|
2007
|
62 |
4 |
p. 667-672
|
artikel
|
Tijdschrift beschrijving